Mydecine Innovations Group

United States Founded: 2010 • Age: 16 yrs Acquired By NewLeaf Brands
Herbal drugs are manufactured and developed by the company.
Request Access
Report Incorrect Data

About Mydecine Innovations Group

Mydecine Innovations Group is a company based in United States founded in 2010 was acquired by NewLeaf Brands in April 2020.. Mydecine Innovations Group has raised $2.65 million across 7 funding rounds from investors including NewLeaf Brands. Mydecine Innovations Group has completed 2 acquisitions, including iLoveVida and unknown.

  • Headquarter United States
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Legal Name Mydecine Innovations Group, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies → →
Key Metrics
  • Annual Revenue
    $0 (USD)
    0
    as on Dec 31, 2024
  • Net Profit
    $-2.19 M (USD)
    84.95
    as on Dec 31, 2024
  • EBITDA
    $-1.76 M (USD)
    76.61
    as on Dec 31, 2024
  • Total Equity Funding
    $2.65 M (USD)

    in 7 rounds

  • Latest Funding Round
    $245 K (USD), Post-IPO

    Aug 15, 2022

  • Investors
    NewLeaf Brands
  • Employee Count
    Employee Count
  • Investments & Acquisitions
    iLoveVida

    & 1 more

  • Acquired by
    NewLeaf Brands

    (Apr 06, 2020)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Mydecine Innovations Group

Mydecine Innovations Group is a publicly listed company on the CSE with ticker symbol MYCO in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: CSE · Ticker: MYCO . Sector: Health technology · Canada

Funding Insights of Mydecine Innovations Group

Mydecine Innovations Group has successfully raised a total of $2.65M across 7 strategic funding rounds. The most recent funding activity was a Post-IPO round of $245 thousand completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 7
  • Last Round Post-IPO — $244,999
  • First Round

    (30 Jun 2010)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2022 Amount Post-IPO - Mydecine Innovations Group Valuation

investors
Jun, 2022 Amount Post-IPO - Mydecine Innovations Group Valuation

investors
Dec, 2021 Amount Post-IPO - Mydecine Innovations Group Valuation

investors
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners

Investors in Mydecine Innovations Group

Mydecine Innovations Group has secured backing from 1 investor. Prominent investors backing the company include NewLeaf Brands. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
NewLeaf Brands
Recreational and medicinal cannaboidal products are manufactured.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Amitabh Bachchan family office
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Signite Partners
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Sixteenth Street Capital
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
GGV Capital
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Mydecine Innovations Group

Mydecine Innovations Group has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include iLoveVida and unknown. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bento Cloud
Bionic investment advisor platform
2016
48East
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
GrabKios by Kudo
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
48East
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
iLoveVida
Provider of cannabis medical services
2019
unknown
-
0
Company Name Description Domain Location Founded Year Amount
OVO
OVO is recognized as a smart digital payment application.
2017
Bento Cloud
Bionic investment advisor platform
2016
GrabKios by Kudo
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
GrabKios by Kudo
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Mydecine Innovations Group

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners

Mydecine Innovations Group Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Mydecine Innovations Group

Company Name Domain Founded year HQ Location Description
inDrive
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
Bolt
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
Gojek
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
Dunzo
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Mydecine Innovations Group

Frequently Asked Questions about Mydecine Innovations Group

When was Mydecine Innovations Group founded?

Mydecine Innovations Group was founded in 2010.

Where is Mydecine Innovations Group located?

Mydecine Innovations Group is headquartered in United States.

Is Mydecine Innovations Group a funded company?

Mydecine Innovations Group is a funded company, having raised a total of $2.65M across 7 funding rounds to date. The company's 1st funding round was a Post-IPO of $4.35M, raised on Jun 30, 2010.

What does Mydecine Innovations Group do?

Mydecine Innovations Group was established in 2010 in the United States. Operations center on the manufacturing of herbal drugs within the pharmaceutical sector. Emphasis is placed on producing natural, plant-based medicinal products. The company maintains a presence through its domain, mydecine.com, supporting distribution and information dissemination. Activities are conducted primarily in the U.S., targeting herbal innovation for health applications.

Is Mydecine Innovations Group publicly traded?

Yes, Mydecine Innovations Group is publicly traded on CSE under the ticker symbol MYCO.

How many acquisitions has Mydecine Innovations Group made?

Mydecine Innovations Group has made 2 acquisitions, including iLoveVida, and unknown.

Who are Mydecine Innovations Group's investors?

Mydecine Innovations Group has 1 investor. Key investors include NewLeaf Brands.

What is Mydecine Innovations Group's ticker symbol?

The ticker symbol of Mydecine Innovations Group is MYCO on CSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available